Skip to main content

Kwietniak Matthew R.'s Form 4 filing

Avid Bioservices, Inc. (CDMO) · filed Jul 11, 2024

Accession no.
0001683168-24-004763
Filed
Jul 11, 2024
Trade date
Jul 9-10, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market sales total $3.35K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kwietniak Matthew R.CIK 0001974519Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 9, 2024Common Stock, $0.001 par valueMOption exerciseAcquired+1,267–F1–23,064Direct
Jul 10, 2024Common Stock, $0.001 par valueSSaleDisposed−444$7.54−$3,347.7622,620Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 9, 2024Common StockMOption exerciseAcquired+95,833$0.00$0170,565Direct
Jul 9, 2024Common StockMOption exerciseAcquired+47,916$0.00$079,812Direct
Jul 9, 2024Common StockDReturned to the companyDisposed−636$0.00$079,176Direct
Jul 9, 2024Common StockDReturned to the companyDisposed−631$0.00$078,545Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)